Bezafibrate

Known as: Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl-, Bezafibratum, 2-(P-(2-(P-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid 
An agonist of peroxisome proliferator-activated receptor alpha (PPARalpha) with antilipidemic activity. Bezafibrate decreases triglyceride levels… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
OBJECTIVE The development of these guidelines is mandated by the American Association of Clinical Endocrinologists (AACE) Board… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
We evaluated the effects of bezafibrate, a peroxisome proliferator-activated receptor (PPAR) pan-agonist, and GW501516, a… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
BACKGROUND A consistent relationship between metabolic syndrome (MS) and myocardial infarction (MI) has been demonstrated. We… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Review
2005
Review
2005
There are three peroxisome proliferator-activated receptors (PPARs) subtypes which are commonly designated PPAR alpha, PPAR gamma… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND Recent studies have shown that type 2 diabetes is preventable by both lifestyle interventions and medications that… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
OBJECTIVE To assess the effect of bezafibrate on the risk of coronary heart disease and stroke in men with lower extremity… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2002
Highly Cited
2002
The elimination of selected pharmaceuticals (bezafibrate, clofibric acid, carbamazepine, diclofenac) during drinking water… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
BACKGROUND Coronary heart disease patients with low high-density lipoprotein cholesterol (HDL-C) levels, high triglyceride levels… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
OBJECTIVE To determine whether serum lipid intervention, in addition to conventional diabetes treatment, could alter… (More)
Is this relevant?
Highly Cited
1996
Highly Cited
1996
BACKGROUND Bezafibrate has effects on lipid metabolism and haemostatic function. We undertook a double-blind, placebo-controlled… (More)
Is this relevant?